Abstract

Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules

Author(s): Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson

Issue: Mar/Apr 2017 - Volume 21, Number 2

Page(s): 171-175

Download in electronic PDF format for $75
  • Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Page 1
  • Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Page 2
  • Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Page 3
  • Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Page 4
  • Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Page 5

Abstract

The objective of this study was to determine the variation in content of 74 different active pharmaceutical ingredients (APIs) and compare it with what is known in the literature for the content uniformity of extemporaneous prepared capsules. Active pharmaceutical ingredients quantification was performed by high-performance liquid chromatography, via a stability-indicating method. Samples for all active pharmaceutical ingredients were taken throughout a 90-day period and the content was determined. In total, 5,190 different samples were analyzed for 74 different active pharmaceutical ingredients at room (15°C to 25°C) or controlled refrigerated temperature (2°C to 8°C). Each of these datasets was analyzed according to the United States Pharmacopeia Content Uniformity monograph, corrected for the sample number. The mean acceptance values were well within specifications. In addition, all suspensions complied with the criteria defined by the British Pharmacopoeia monograph for Content Uniformity of Liquid Dispersions for both room and controlled refrigerated temperature. In previous studies, it was found that a routine weight variation check is often not sufficient for quality assurance of extemporaneous prepared capsules. Compounded oral liquids show little variation in content for 74 different active pharmaceutical ingredients; therefore, compounded oral liquids are a suitable alternative when compounding individualized medications for patients.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2017
Pg. 171-175
May/Jun 2019
Pg. 258-263
Mar/Apr 2020
Pg. 92
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 180
Author(s): Allen Loyd V Jr
Sep/Oct 2020
Pg. 408-412
Mar/Apr 2019
Pg. 135-143
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 115-124
Author(s): Kelley Brian
May/Jun 2016
Pg. 257-261
May/Jun 2017
Pg. 180
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 257-260
May/Jun 2011
Pg. 224-232
May/Jun 2016
Pg. 247-249
Author(s): Nahata Milap C
Mar/Apr 2012
Pg. 146-150
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496
Author(s): Allen Loyd V Jr
Jan/Feb 2012
Pg. 64-68
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 328-331
Author(s): Allen Loyd V Jr
Jan/Feb 2010
Pg. 21-25
Jul/Aug 2007
Pg. 302-305
Author(s): Okeke Claudia C
Jan/Feb 2001
Pg. 6-8
Author(s): Preckshot John
Nov/Dec 2011
Pg. 488-496
Author(s): Allen Loyd V Jr